| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Ivor Elrifi is Chief Executive Officer at TLSA. Ivor Elrifi's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.0M at current prices.
Net of sales, the TLSA filings show accumulation of 988,423 shares.
Ivor Elrifi has 3 Form 4 filings on record in August 2026, all as Chief Executive Officer at Tiziana Life Sciences (TLSA), 2026.
The 4 reported transactions were 3 open-market purchases and 1 option exercise.
Counted by filing, the open-market trades come to 2 purchases worth about $986K and no sales.
The largest open-market purchase was 667,000 shares of TLSA at an average $1.00 on August 3, 2026, about $667K.